atorvastatin has been researched along with nephrin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bob, F; Dumitrascu, V; Gadalean, F; Gluhovschi, C; Gluhovschi, G; Jianu, DC; Matusz, P; Petrica, L; Popescu, R; Secara, A; Simulescu, A; Ursoniu, S; Velciov, S; Vlad, A; Vlad, D; Vlad, M | 1 |
1 trial(s) available for atorvastatin and nephrin
| Article | Year |
|---|---|
Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study.
Topics: Aged; Albuminuria; Atorvastatin; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules, Proximal; Male; Membrane Proteins; Middle Aged; Pilot Projects; Podocytes; Prospective Studies; Rosuvastatin Calcium; Vascular Endothelial Growth Factor A | 2017 |